Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Transmedics Group Inc

TMDX ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Advanced Medical Equipment & Technology ·

USA Mid Cap Analyst: BUY

Last Close

$88.58

▼ -1.18%

Market Cap $3.07B · Vol 157.24K

Key Metrics

P/E Ratio

23.24

FWD: 44.76

Market Cap

$3.07B

Mid Cap

Div Yield

N/A

EPS Growth

-40.80%

YoY

RSI (14)

70.45

Momentum

Beta

1.89

vs Market

52W High

$155.73

43.12% below

52W Low

$60.13

47.31% above

Volume

157.24K

Avg 297.79K

P/B

8.81

Price-to-book

ROE

54.24%

Return on equity

Free Float

96.36%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Transmedics Group Inc (TMDX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does TMDX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+5.59%

+18.76%

+42.78%

-31.78%

YTD

-27.18%

-31.72%

+40.63%

+204.82%

Financials & Valuation

TTM · Annual

Total Revenue	$605.49M
Net Income	$190.29M
Revenue Growth (YoY)	+20.70%
Gross Margin	59.92%
Operating Margin	17.93%
Net Profit Margin	31.43%
ROE	54.24%
ROA · ROIC	11.48% · 24.91%

P/E Ratio	23.24
Forward P/E (FY1)	44.76
PEG Ratio	0.07
P/S	8.15
P/B	8.81
P/FCF	36.92
EPS Growth	-40.80%
Outstanding Shares	34.68M

Technical Indicators

50-Day SMA	$75.51
200-Day SMA	$107.30
RSI (14)	70.45
Beta	1.89
52-Week High	$155.73
52-Week Low	$60.13

Volume Today	157.24K
Avg Daily Volume (30D)	297.79K
Relative Volume	0.53x
Volatility (10D)	58.78
Volatility (30D)	46.17
Free Float	96.36%

Analyst Consensus

BUY

Current Price $88.58

Mean Target $105.89

52W Low$60.13 52W High$155.73

Current

Target

$60.13 $155.73

Current Analyst target

+19.54% upside potential · 13 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00NZ6J701

ISINUS89377M1099

CountryUnited States of America

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateOct 27, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -1.28% DHR Danaher Corp -0.71% ISRG Intuitive Surgical Inc -1.68% BSX Boston Scientific Corp +0.27% EW Edwards Lifesciences Corp -1.04%

Company Profile

TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.